Company Filing History:
Years Active: 2006
Title: Robin Breckenridge: Innovator in Pharmaceutical Chemistry
Introduction
Robin Breckenridge is a notable inventor based in Hagenthal-le-Bas, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that interact with somatostatin receptors. His work has implications for various therapeutic applications.
Latest Patents
Breckenridge holds a patent for "Hydantoin derivatives with affinity for somatostatin receptors." This invention provides compounds of formula (I), wherein X, Y, R, R, and R are defined in the description. The compounds bind to somatostatin receptors and are useful as pharmaceuticals. He has 1 patent to his name.
Career Highlights
Breckenridge is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to work on innovative solutions that address critical health challenges. His expertise in pharmaceutical chemistry has been instrumental in advancing the company's research initiatives.
Collaborations
Throughout his career, Breckenridge has collaborated with esteemed colleagues, including Daniel Berney and Peter Neumann. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.
Conclusion
Robin Breckenridge is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His contributions to the field, particularly in the development of somatostatin receptor-binding compounds, highlight his commitment to advancing healthcare solutions.